# Ankeet S. Bhatt

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ankeet-s-bhatt/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,260 |
| Field | Heart Failure Treatment and Management |
| h-index | 28 |
| i10-index | 64 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5061823235 |
| ORCID iD | 0000-0002-6449-4535 |
| Works | 227 |

## Researcher papers

- [Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic](https://scholariq.org/papers/fewer-hospitalizations-for-acute-cardiovascular-conditions-during-the-covid-19/)
- [Clinical Outcomes in Young US Adults Hospitalized With COVID-19](https://scholariq.org/papers/clinical-outcomes-in-young-us-adults-hospitalized-with-covid-19/)
- [Adverse Remodeling and Reverse Remodeling After Myocardial Infarction](https://scholariq.org/papers/adverse-remodeling-and-reverse-remodeling-after-myocardial-infarction/)
- [Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19](https://scholariq.org/papers/clinical-outcomes-in-patients-with-heart-failure-hospitalized-with-covid-19/)
- [Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial](https://scholariq.org/papers/impact-of-primary-kidney-disease-on-the-effects-of-empagliflozin-in-patients/)
- [De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry](https://scholariq.org/papers/de-novo-vs-acute-on-chronic-presentations-of-heart-failure-related-cardiogenic/)
- [Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial](https://scholariq.org/papers/effects-of-empagliflozin-on-progression-of-chronic-kidney-disease-a-prespecified/)
- [Incidence and Outcomes of Pneumonia in Patients With Heart Failure](https://scholariq.org/papers/incidence-and-outcomes-of-pneumonia-in-patients-with-heart-failure/)
- [Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT](https://scholariq.org/papers/anticoagulation-and-antiplatelet-therapy-for-prevention-of-venous-and-arterial/)
- [Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial](https://scholariq.org/papers/electronic-nudges-to-increase-influenza-vaccination-uptake-in-denmark-a/)
- [Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System](https://scholariq.org/papers/sex-based-differences-in-the-epidemiology-clinical-characteristics-and-outcomes/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Influenza Virus Research Studies](https://scholariq.org/topics/influenza-virus-research-studies/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.